
11.58MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US2312693094
CUSIP
231269200
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.32
Dividend Share
-
Dividend Yield
-
Earnings Share
-11.6
Wall Street Target Price
280.00
EPS Estimate Current Year
-31.20
EPS Estimate Next Year
-23.73
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.53
Most Recent Quarter
-
Revenue TTM
7,063,000
Gross Profit TTM
-19,132,000
EBITDA
-34,111,752
Profit Margin
-299.66%
Return On Assets TTM
-62.06%
Return On Equity TTM
-693.93%
Revenue Per Share TTM
8.895
Qtly Revenue Growth YOY
-66.00%
Diluted Eps TTM
-11.6
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
1.4597
Price Book MRQ
1.0632
Enterprise Value Revenue
36
Enterprise Value EBITDA
0
323.66
0.61%296.81
0.61%935.38
0.00%501.99
-3.85%662.88
-2.07%144.63
-1.16%189.20
-0.65%21.68
-0.50%86.38
-0.48%916.50
-0.29%